课题基金 / 基金详情

Eval. of Minocycline as a Microglia Inhibitor in Tx of Diabetic Macular Edema

Eval. of Minocycline as a Microglia Inhibitor in Tx of Diabetic Macular Edema
评估。
批准号:
9155595
负责人:
Catherine Cukras
金额:
$6.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Catherine Cukras的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
There is accumulating evidence that retinal microglia are indeed associated with diabetic retinopathy. Minocycline is a second-generation tetracycline, which has anti-inflammatory properties that are separate from its anti-microbial properties. The study objective is to investigate the safety and efficacy of minocycline, a microglia inhibitor, in the treatment of diabetic macular edema. This is a prospective, non-randomized, uncontrolled, single group, single center pilot study to investigate the safety and efficacy of minocycline as a microglia inhibitor in patients with DME who have already been treated with standard-of-care laser or who are not amenable to standard-of-care therapy. The study has ended but we continue to analyze the data.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Eval. of Minocycline as a Microglia Inhibitor in Tx of CRVO and BRVO
  • 批准号:
    8737681
  • 项目类别:
  • 资助金额:
    $15.84万
  • 财政年份:
    --
  • 负责人:
    Catherine Cukras
  • 依托单位:
Longitudinal Investigation of Dark Adaptation in Participants with AMD
  • 批准号:
    8737669
  • 项目类别:
  • 资助金额:
    $14.18万
  • 财政年份:
    --
  • 负责人:
    Catherine Cukras
  • 依托单位:
Longitudinal Investigation of Dark Adaptation in Participants with AMD
  • 批准号:
    8556871
  • 项目类别:
  • 资助金额:
    $13.64万
  • 财政年份:
    --
  • 负责人:
    Catherine Cukras
  • 依托单位:
Eval. of Minocycline as a Microglia Inhibitor in Tx of CRVO and BRVO
  • 批准号:
    9155610
  • 项目类别:
  • 资助金额:
    $29.38万
  • 财政年份:
    --
  • 负责人:
    Catherine Cukras
  • 依托单位:
海外基金